• Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Germany Spain
  • Study to Test BI 765845 for Patients with Heart Attack

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Hungary Italy Poland Slovakia +1
  • Study on the Effects and Safety of PLX038 for Patients with Advanced or Metastatic Triple-Negative Breast Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    France
  • Study of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer

    Not recruiting

    2 1 1
    France Italy Spain
  • Study on the Safety and Effectiveness of Atrasentan for Patients with IgA Nephropathy Taking SGLT2 Inhibitors

    Not recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

    Not recruiting

    2 1 1 1
    Belgium France The Netherlands Spain
  • Study of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands
  • Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

    Not recruiting

    2 1 1
    Austria Belgium France Germany Spain
  • Study on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany
  • Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland

powered by